United Therapeutics | UTHR - Marktkapitalisierung

Aktienkurs
568.58
Täglich Wechseln
-7.21 -1.25%
Monatlich
-2.06%
Jährlich
86.21%
Q2 Prognose
557.15




Marktkapitalisierung Veränderung Datum
Amarin USD 290M 51M 2025-12
Baxter International USD 8.67B 1.15B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 8.44B 781M 2026-05
Insmed USD 15.56B 19.73B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Moderna USD 20.15B 8.53B 2026-03
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
United Therapeutics USD 28.08B 2.9B 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05